Gauging Patient- and Family-Perceived Value of Genetic Testing for Atrial Fibrillation
There is accumulating evidence that genetic variation can cause or affect susceptibility to atrial fibrillation (AF) [1]. Although this argues for incorporation of genetic testing into clinical management, there is a lack of understanding of consumer interest in being tested and the value placed on genomic information about AF. Accordingly, this study aimed to investigate the perceived value of genetic testing for AF.
Authors
- Zoe Fehlberg (ORCID: https://orcid.org/0000-0002-8449-206X)
- Ilias Goranitis (ORCID: https://orcid.org/0000-0001-7946-8324)
- Stephanie Best (ORCID: https://orcid.org/0000-0002-1107-8976)
- Nathasha Kugenthiran
- Min Li (ORCID: https://orcid.org/0000-0002-0072-5912)
- D Fatkin
Institutions
- The University of Melbourne (AU)
- Victor Chang Cardiac Research Institute (AU)
- Murdoch Children's Research Institute (AU)
Publication Details
- Journal
- Heart Lung and Circulation
- Published
- 2026-02-05
- DOI
- https://doi.org/10.1016/j.hlc.2025.09.008
- Citations
- 1
- Primary Topic
- BRCA gene mutations in cancer
- Type
- article
- Field-Weighted Citation Impact
- 30.93
Funders
- NSW Ministry of Health